Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 521.45M P/E - EPS this Y 57.70% Ern Qtrly Grth -
Income -29.04M Forward P/E 42.86 EPS next Y 150.70% 50D Avg Chg 1.00%
Sales 94.32M PEG - EPS past 5Y - 200D Avg Chg 60.00%
Dividend N/A Price/Book 18.01 EPS next 5Y - 52W High Chg -
Recommedations 3.00 Quick Ratio 2.29 Shares Outstanding 34.76M 52W Low Chg 389.00%
Insider Own 0.19% ROA -14.56% Shares Float 34.34M Beta 0.98
Inst Own 34.47% ROE -72.53% Shares Shorted/Prior 816.84K/0.97M Price 15.00
Gross Margin 59.93% Profit Margin -30.79% Avg. Volume 564,056 Target Price 15.00
Oper. Margin -25.97% Earnings Date Mar 13 Volume 245,298 Change 0.00%
About AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer. It markets FOTIVDA, an oral, next-generation vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC). The company is also developing tivozanib for the treatment of RCC, hepatocellular carcinoma, ovarian cancer, immunologically cold tumors, and cholangiocarcinoma. In addition, it is developing Ficlatuzumab, a potent humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor that is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma, pancreatic cancer, and acute myeloid leukemia; AV-380, a potent humanized IgG1 inhibitory monoclonal antibody for the treatment or prevention of cachexia; AV-203, a potent humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353 that targets the Notch 3 pathway. The company has collaborations and license agreements with AstraZeneca PLC; EUSA Pharma (UK) Limited; Biodesix, Inc.; CANbridge Life Sciences, Ltd.; Biogen Idec International GmbH; St. Vincent's Hospital Sydney Limited; and Kyowa Kirin Co., Ltd. The company was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Boston, Massachusetts.

AVEO Chatroom

User Image NVDAMillionaire Posted - 3 months ago

$AVEO AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO): A Promising Oncology-Focused Biopharmaceutical Company with Significant Potential http://beyondspx.com/2024/08/05/aveo-pharmaceuticals-inc-nasdaqaveo-a-promising-oncology-focused-biopharmaceutical-company-with-significant-potential/

User Image cmeola1066 Posted - 4 months ago

$AVEO Here's what a competent Chair/CEO looks like. Now I'm glad to have been a Bailey shareholder. $ENVX https://youtu.be/udYL80r3Z7I?si=C8ZLVJcRd454Srku

User Image DeStockRapist Posted - 5 months ago

@VigilantHamster @Tdwight look at $AVEO price action before the 15$ buyout, they dropped it to 3$ beforehand...

User Image DeStockRapist Posted - 7 months ago

$AKBA never felt this close from a buyout since $AVEO with same pattern and gap fill even with approval in hand. Everything is in place, just gotta wait it out and take advantage of fake weakness. Market makers always play their games to shake out investors but value wins every time on a buyout play.

User Image Moonship Posted - 7 months ago

$ATOR.X will soon be in price discovery ! $AVEO and $AERO.X also big breakout coming. $AERO.X is the main investment vehicle for @CoinbaseInc Base ecosystem - it'll sOon have a MC in the billions.

User Image AZona Posted - 7 months ago

$DAWN back in here. Taking advantage of a red week in the market 😬 PDUFA: Tuesday, April 30, 2024 💪 Current holds I’ve been adding to all week: $XFOR $AVEO $AKBA $AQST 💜

User Image Stock_Titan Posted - 9 months ago

$AVEO AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist https://www.stocktitan.net/news/AVEO/aveo-oncology-announces-publication-of-long-term-survival-in-g3ia1pitqueo.html

User Image STCKPRO Posted - 10 months ago

$AVEO NEW ARTICLE : AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) https://www.stck.pro/news/AVEO/72860129/

User Image Ruffy__ Posted - 10 months ago

$AUPH news out yet? BO are announced before market open? Not sure when they announced $AVEO buyout back then. I want my second buyout. DO IT NOW ☺️

User Image jskwodjd Posted - 12/22/23

$AVEO still wondering about that lady that wasted her husbands life savings on this

User Image Bradi2i Posted - 11 months ago

$AVEO Watch $AVXL

User Image TrendyChart Posted - 10/26/23

Upcoming Earnings Report: $AVEO AVEO Pharmaceuticals will be reporting on 11/06/2023 at 4:00PM | What's your take on the earnings potential of this stock?

User Image stockilluminati Posted - 1 year ago

$AVEO https://clinicaltrials.gov/study/NCT06064877 - trial update posted here!

User Image stockilluminati Posted - 1 year ago

$AVEO https://clinicaltrials.gov/study/NCT06064877 - trial update posted here!

User Image stockilluminati Posted - 1 year ago

$AVEO https://clinicaltrials.gov/study/NCT06066437 - trial update posted here!

User Image stockilluminati Posted - 1 year ago

$AVEO https://www.stockilluminati.com/aveo/display.php?url=https://clinicaltrials.gov/study/NCT06064877 - trial update posted here!

User Image stockilluminati Posted - 1 year ago

$AVEO https://www.stockilluminati.com/aveo/display.php?url=https://clinicaltrials.gov/study/NCT06066437 - trial update posted here!

User Image stockilluminati Posted - 1 year ago

$AVEO https://www.stockilluminati.com/aveo/display.php?url=https://clinicaltrials.gov/study/NCT06064877 - trial update posted here!

User Image stockilluminati Posted - 1 year ago

$AVEO https://www.stockilluminati.com/aveo/display.php?url=https://clinicaltrials.gov/study/NCT06064877 - trial update posted here!

User Image cmeola1066 Posted - 09/29/23

$CAPR I'm just hoping this story doesn't wind up like another pharm spec I had: $AVEO. Held for 5 years and the company was sold for a lousy $15. Only some well timed calls gave me any kind of pump. But yeah today's one of those arrow in the ass days. Announce the offering at end of quarter and keep fingers crossed the medicine is swallowed quick

User Image cmeola1066 Posted - 1 year ago

@wkee I was a shareholder of $AVEO for 5 years. At the end of the day the company sold for $15/share, roughly a 3X. Not a bust, but didn't make any long term investor satisfied. The sad fact is that the Federal Death Authority is nothing more than a state agency; and the STATE is no one's friend.

User Image cmeola1066 Posted - 1 year ago

@Mesaboogie Brad, check out $CAPR. This tiny bio play is right up your alley. Risk/reward is better than our old lady $AVEO. Just sayin

User Image GoonKing Posted - 08/31/23

$PIII volume/ insider buys $ICCT halt $AVEO 👀

User Image cmeola1066 Posted - 1 year ago

$AVEO I’m seeing Aveo everywhere 🌈🦄Gold backed currency is back biatches

User Image stockilluminati Posted - 1 year ago

$AVEO https://www.stockilluminati.com/aveo/display.php?url=https://clinicaltrials.gov/ct2/show/NCT05865535 - trial update posted here!

User Image NorthWestHawk Posted - 1 year ago

…Recent HOOK cluster of massive pocket pivots reminds me $AVEO in June 2022 quickly rising from $4 to $7. After that $AVEO steadily climbed to $10, and then finally was BO at $15 in October 2022. i.e. $AVEO, became almost a bagger in a blink of an eye. I'm 💎 🙌 holding HOOK.

User Image ians Posted - 1 year ago

$HURA Buy DIPs & HODL. $5.7M valuation is a bargain. If VAL-083 gets approved for 3/4L treatment for GBM, that MC could balloon to $500M+ on a BO. Just remember how $AVEO TiVo got approved first as 3/4L treatment for RCC before getting BO for ~$566M in cash🤑☘️💎 https://stocktwits.com/ians/message/284155321

User Image DeStockRapist Posted - 03/26/23

$AKBA Came on this one tryna find the next $AVEO and seen some familiar faces. This one is clearly another buyout material. Good revenues already, upcoming drug with many catalyst and Pr's upcoming, and enough good cash on hand to not be worried about and overnight raise . Even if it's all looking good, most important part is the scaling and timing of my buyin. With depressed SP and low valuation already, risk reward is right in my wheelhouse. I actually want this to go lower so I can buy more for less and all you longs here with good DD should have that perspective if you truly believe. They will manipulate this until you loose patience and sell just like AVEO when it dropped to 3$ even being in talk for a 15$ buyout. Think about it, understand their game and play it right. We have a goldmine here.

User Image tickeron Posted - 03/26/23

Which stock is the best to invest? Compare $AVEO vs. $FC. #AVEOPharmaceuticals https://srnk.us/go/4516930

User Image risenhoover Posted - 03/25/23

$AVEO AVEO / AVEO Pharmaceuticals, Inc. Price Target Updated https://fintel.io/sfo/us/aveo?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

Analyst Ratings
Stifel Hold Nov 8, 22
JonesTrading Hold Oct 31, 22
SVB Leerink Market Perform Oct 24, 22
Baird Neutral Oct 19, 22
HC Wainwright & Co. Neutral Oct 18, 22
HC Wainwright & Co. Buy Jul 12, 21
SVB Leerink Outperform Mar 11, 21
SVB Leerink Outperform Jan 19, 21
SVB Leerink Outperform Nov 25, 20